Central Nervous System (CNS) Stimulant Drugs Market to Reach USD 9317.31 million by 2030
%20Stimulant%20Drugs%20Market.jpeg)
The latest market report published by Credence Research, Inc. The global demand for central nervous system (CNS) stimulant drugs market was valued at USD 5845.8 million in 2022 and is expected to reach USD 9317.31 million in 2030, growing at a CAGR of 6.00% between 2023 and 2030. The Central Nervous System (CNS) stimulant drugs market has witnessed significant growth in recent years, driven by the increasing prevalence of neurological disorders, attention deficit hyperactivity disorder (ADHD), and the need for enhanced cognitive performance. CNS stimulant drugs play a pivotal role in treating these conditions, and their market has been expanding steadily as a result. Market Size and Growth: The global CNS stimulant drugs market has experienced remarkable growth, with projections showing continued expansion. Factors contributing to this growth include a rising awareness of neurological disorders, a surge in research and development efforts, and advancements in ...